메뉴 건너뛰기




Volumn 58, Issue 2, 2010, Pages 131-141

Plasma TNF-α and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-cell lymphoma in different risk groups defined by the international prognostic index

Author keywords

Diffuse large B cell lymphoma; Interleukin 10; International Prognostic Index; Tumor necrosis factor

Indexed keywords

ANTHRACYCLINE; BETA 2 MICROGLOBULIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; INTERLEUKIN 10; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; VINCRISTINE; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CHOP PROTOCOL; IL10 PROTEIN, HUMAN;

EID: 77952781844     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-010-0066-1     Document Type: Article
Times cited : (40)

References (33)
  • 1
    • 0027444652 scopus 로고
    • A predictive model for aggressive non-Hodgkin's lymphoma
    • The International Non-Hodgkin's Lymphoma Prognostic Factors Project
    • -(1993) A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987-994
    • (1993) N Engl J Med , vol.329 , pp. 987-994
  • 2
    • 85047692516 scopus 로고    scopus 로고
    • Signalling pathways of the TNF superfamily: A double-edged sword
    • 10.1038/nri1184 1:CAS:528:DC%2BD3sXmvVWmtb0%3D 12949498
    • BB Aggarwal 2003 Signalling pathways of the TNF superfamily: a double-edged sword Nat Rev Immunol 3 745 756 10.1038/nri1184 1:CAS:528:DC%2BD3sXmvVWmtb0%3D 12949498
    • (2003) Nat Rev Immunol , vol.3 , pp. 745-756
    • Aggarwal, B.B.1
  • 3
    • 0034894958 scopus 로고    scopus 로고
    • Inhibition of interleukin 10 by Rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis
    • 1:CAS:528:DC%2BD3MXjtVOnsr0%3D 11297268
    • S Alas C Emmanouilides B Bonavida 2001 Inhibition of interleukin 10 by Rituximab results in down-regulation of bcl-2 and sensitization of B-cell non-Hodgkin's lymphoma to apoptosis Clin Cancer Res 7 709 723 1:CAS:528:DC%2BD3MXjtVOnsr0%3D 11297268
    • (2001) Clin Cancer Res , vol.7 , pp. 709-723
    • Alas, S.1    Emmanouilides, C.2    Bonavida, B.3
  • 4
    • 0026784556 scopus 로고
    • Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10
    • 1:CAS:528:DyaK3sXlsl2gsw%3D%3D 1325212
    • D Benjamin TJ Knobloch MA Dayton 1992 Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10 Blood 80 1289 1298 1:CAS:528:DyaK3sXlsl2gsw%3D%3D 1325212
    • (1992) Blood , vol.80 , pp. 1289-1298
    • Benjamin, D.1    Knobloch, T.J.2    Dayton, M.A.3
  • 5
    • 0027434991 scopus 로고
    • Serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor
    • 1:STN:280:DyaK2c%2Fgtlaksg%3D%3D 8400266
    • JY Blay N Burdin F Rousset, et al. 1993 Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor Blood 82 2169 2174 1:STN:280:DyaK2c%2Fgtlaksg%3D%3D 8400266
    • (1993) Blood , vol.82 , pp. 2169-2174
    • Blay, J.Y.1    Burdin, N.2    Rousset, F.3
  • 6
    • 0042449063 scopus 로고    scopus 로고
    • Report of an international workshop to standardize response criteria for non-Hodgkin's lymphoma
    • 1:STN:280:DC%2BD3c%2FivF2itg%3D%3D 10561185
    • BD Cheson SJ Horning B Coiffier, et al. 1999 Report of an international workshop to standardize response criteria for non-Hodgkin's lymphoma J Clin Oncol 17 1244 1253 1:STN:280:DC%2BD3c%2FivF2itg%3D%3D 10561185
    • (1999) J Clin Oncol , vol.17 , pp. 1244-1253
    • Cheson, B.D.1    Horning, S.J.2    Coiffier, B.3
  • 7
    • 0024379544 scopus 로고
    • LNH-84 regimen: A multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma
    • 1:STN:280:DyaL1MzivVCktA%3D%3D 2474057
    • B Coiffier C Gisselbrecht R Herbrecht, et al. 1989 LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma J Clin Oncol 7 1018 1026 1:STN:280:DyaL1MzivVCktA%3D%3D 2474057
    • (1989) J Clin Oncol , vol.7 , pp. 1018-1026
    • Coiffier, B.1    Gisselbrecht, C.2    Herbrecht, R.3
  • 10
    • 0029075329 scopus 로고
    • Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas
    • 1:CAS:528:DyaK2MXmtlOmtrs%3D 7780126
    • HJ Gruss SK Dower 1995 Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas Blood 85 3378 3404 1:CAS:528:DyaK2MXmtlOmtrs%3D 7780126
    • (1995) Blood , vol.85 , pp. 3378-3404
    • Gruss, H.J.1    Dower, S.K.2
  • 12
    • 33646410446 scopus 로고    scopus 로고
    • Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: High interleukin-5 and -10 levels are significant unfavorable prognostic factors
    • 10.1002/ijc.21688 1:CAS:528:DC%2BD28XksVKlu74%3D 16425276
    • A Inagaki T Ishida T Ishii, et al. 2006 Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors Int J Cancer 118 3054 3061 10.1002/ijc.21688 1:CAS:528:DC%2BD28XksVKlu74%3D 16425276
    • (2006) Int J Cancer , vol.118 , pp. 3054-3061
    • Inagaki, A.1    Ishida, T.2    Ishii, T.3
  • 13
    • 25844459154 scopus 로고    scopus 로고
    • NF-κB: Linking inflammation and immunity to cancer development and progression
    • DOI 10.1038/nri1703
    • M Karin FR Greten 2005 NF-kappaB: linking inflammation and immunity to cancer development and progression Nat Rev Immunol 5 749 759 10.1038/nri1703 1:CAS:528:DC%2BD2MXhtVGrurvL 16175180 (Pubitemid 41400849)
    • (2005) Nature Reviews Immunology , vol.5 , Issue.10 , pp. 749-759
    • Karin, M.1    Greten, F.R.2
  • 16
    • 33746083294 scopus 로고    scopus 로고
    • Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma
    • 1:CAS:528:DC%2BD28XksVWktrc%3D 16613764
    • E Lech-Maranda J Bienvenu AS Michallet, et al. 2006 Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma Eur Cytokine Netw 17 60 66 1:CAS:528:DC%2BD28XksVWktrc%3D 16613764
    • (2006) Eur Cytokine Netw , vol.17 , pp. 60-66
    • Lech-Maranda, E.1    Bienvenu, J.2    Michallet, A.S.3
  • 17
    • 1642554780 scopus 로고    scopus 로고
    • The multifaceted relationship between IL-10 and adaptive immunity: Putting together the pieces of a puzzle
    • DOI 10.1016/j.cytogfr.2003.11.001
    • S Mocellin F Marincola CR Rossi, et al. 2004 The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle Cytokine Growth Factor Rev 15 61 76 10.1016/j.cytogfr.2003.11.001 1:CAS:528:DC%2BD2cXmvFKktQ%3D%3D 14746814 (Pubitemid 38121291)
    • (2004) Cytokine and Growth Factor Reviews , vol.15 , Issue.1 , pp. 61-76
    • Mocellin, S.1    Marincola, F.2    Rossi, C.R.3    Nitti, D.4    Lise, M.5
  • 18
    • 0035062021 scopus 로고    scopus 로고
    • Interleukin-10 and the interleukin-10 receptor
    • DOI 10.1146/annurev.immunol.19.1.683
    • KW Moore R de Waal Malefyt RL Coffman, et al. 2001 Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 683 765 10.1146/annurev.immunol.19. 1.683 1:CAS:528:DC%2BD3MXivFKgu70%3D 11244051 (Pubitemid 32368050)
    • (2001) Annual Review of Immunology , vol.19 , pp. 683-765
    • Moore, K.W.1    De Waal Malefyt, R.2    Coffman, R.L.3    O'Garra, A.4
  • 19
    • 0037409043 scopus 로고    scopus 로고
    • High tumor necrosis factor-α levels in the patients with Epstein-Barr virus-associated peripheral T-cell proliferative disease/lymphoma
    • DOI 10.1016/S0145-2126(02)00266-7, PII S0145212602002667
    • A Mori S Takao J Pradutkanchana, et al. 2003 High tumor necrosis factor-alpha levels in the patients with Epstein-Barr virus-associated peripheral T-cell proliferative disease/lymphoma Leuk Res 27 493 498 10.1016/S0145-2126(02)00266-7 1:CAS:528:DC%2BD3sXitVymsrY%3D 12648508 (Pubitemid 36315780)
    • (2003) Leukemia Research , vol.27 , Issue.6 , pp. 493-498
    • Mori, A.1    Takao, S.2    Pradutkanchana, J.3    Kietthubthew, S.4    Mitarnun, W.5    Ishida, T.6
  • 21
    • 8544247939 scopus 로고    scopus 로고
    • The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive non-Hodgkin's lymphoma (NHL)
    • 1:STN:280:DC%2BD2cnitVGksA%3D%3D 15595640
    • F Ozdemir F Aydin M Yilmaz, et al. 2004 The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive non-Hodgkin's lymphoma (NHL) J Exp Clin Cancer Res 23 485 488 1:STN:280:DC%2BD2cnitVGksA%3D%3D 15595640
    • (2004) J Exp Clin Cancer Res , vol.23 , pp. 485-488
    • Ozdemir, F.1    Aydin, F.2    Yilmaz, M.3
  • 22
    • 0037644804 scopus 로고    scopus 로고
    • Biological functions of tumor necrosis factor cytokines and their receptors
    • DOI 10.1016/S1359-6101(03)00022-4
    • K Pfeffer 2003 Biological functions of tumor necrosis factor cytokines and their receptors Cytokine Growth Factor Rev 14 185 191 10.1016/S1359-6101(03) 00022-4 1:CAS:528:DC%2BD3sXkt1Ghsr0%3D 12787558 (Pubitemid 36693140)
    • (2003) Cytokine and Growth Factor Reviews , vol.14 , Issue.3-4 , pp. 185-191
    • Pfeffer, K.1
  • 24
    • 0029887909 scopus 로고    scopus 로고
    • Elevated circulating levels of TNF-alpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients
    • 10.1046/j.1365-2141.1996.5181059.x 1:STN:280:DyaK283htlyitQ%3D%3D 8639428
    • G Salles J Bienvenu Y Bastion, et al. 1996 Elevated circulating levels of TNF-alpha and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients Br J Haematol 93 352 359 10.1046/j.1365-2141.1996.5181059. x 1:STN:280:DyaK283htlyitQ%3D%3D 8639428
    • (1996) Br J Haematol , vol.93 , pp. 352-359
    • Salles, G.1    Bienvenu, J.2    Bastion, Y.3
  • 25
    • 0028012062 scopus 로고
    • Prognostic factors in aggressive non-Hodgkin's lymphoma: Who has "high-risk" disease?
    • 1:STN:280:DyaK2c7mt1KisA%3D%3D 8118021
    • MA Shipp 1994 Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease? Blood 83 1165 1173 1:STN:280: DyaK2c7mt1KisA%3D%3D 8118021
    • (1994) Blood , vol.83 , pp. 1165-1173
    • Shipp, M.A.1
  • 26
  • 28
    • 0027131207 scopus 로고
    • Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis
    • 1:CAS:528:DyaK2cXnsFWktQ%3D%3D 8258695
    • C Wanidworanun W Strober 1993 Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis J Immunol 151 6853 6861 1:CAS:528:DyaK2cXnsFWktQ%3D%3D 8258695
    • (1993) J Immunol , vol.151 , pp. 6853-6861
    • Wanidworanun, C.1    Strober, W.2
  • 29
    • 0031833240 scopus 로고    scopus 로고
    • The tumor necrosis factor signaling complex: Choosing a path toward cell death or cell proliferation
    • 10.3109/10428199809058384 1:CAS:528:DC%2BD3cXis1arsro%3D 9638978
    • K Warzocha G Salles 1998 The tumor necrosis factor signaling complex: choosing a path toward cell death or cell proliferation Leuk Lymphoma 29 81 92 10.3109/10428199809058384 1:CAS:528:DC%2BD3cXis1arsro%3D 9638978
    • (1998) Leuk Lymphoma , vol.29 , pp. 81-92
    • Warzocha, K.1    Salles, G.2
  • 30
    • 0030796185 scopus 로고    scopus 로고
    • Prognostic significance of TNF-alpha and its p55 soluble receptor in malignant lymphomas
    • 9209418
    • K Warzocha G Salles J Bienvenu, et al. 1997 Prognostic significance of TNF-alpha and its p55 soluble receptor in malignant lymphomas Leukemia 11 suppl 3 441 443 9209418
    • (1997) Leukemia , vol.11 , Issue.SUPPL 3 , pp. 441-443
    • Warzocha, K.1    Salles, G.2    Bienvenu, J.3
  • 31
    • 0031037239 scopus 로고    scopus 로고
    • Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients
    • 1:STN:280:DyaK2s7nvVOgug%3D%3D 9053471
    • K Warzocha G Salles J Bienvenu, et al. 1997 Tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients J Clin Oncol 15 499 508 1:STN:280:DyaK2s7nvVOgug%3D%3D 9053471
    • (1997) J Clin Oncol , vol.15 , pp. 499-508
    • Warzocha, K.1    Salles, G.2    Bienvenu, J.3
  • 32
    • 0032525156 scopus 로고    scopus 로고
    • Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome
    • 1:CAS:528:DyaK1cXjtFersro%3D 9572991
    • K Warzocha P Ribeiro J Bienvenu, et al. 1998 Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome Blood 91 3574 3581 1:CAS:528:DyaK1cXjtFersro%3D 9572991
    • (1998) Blood , vol.91 , pp. 3574-3581
    • Warzocha, K.1    Ribeiro, P.2    Bienvenu, J.3
  • 33
    • 0037962020 scopus 로고    scopus 로고
    • Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders: A short review
    • DOI 10.1002/cncr.11524
    • A Younes BB Aggarwall 2003 Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders Cancer 98 458 467 10.1002/cncr.11524 1:CAS:528:DC%2BD3sXmsV2mtbk%3D 12879461 (Pubitemid 36885984)
    • (2003) Cancer , vol.98 , Issue.3 , pp. 458-467
    • Younes, A.1    Aggarwall, B.B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.